Insider Buying: Ardent Health (NYSE:ARDT) CFO Acquires $88,100.00 in Stock

Ardent Health, Inc. (NYSE:ARDT) CFO Alfred Lumsdaine bought 10,000 shares of the company’s stock in a transaction on Friday, June 5th. The stock was bought at an average price of $8.81 per share, with a total value of $88,100.00. Following the completion of the acquisition, the chief financial officer owned 329,183 shares in the company, valued at $2,900,102.23. This represents a 3.13% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Ardent Health Stock Down 0.6%

Shares of NYSE:ARDT opened at $9.36 on Thursday. The company has a quick ratio of 2.00, a current ratio of 2.12 and a debt-to-equity ratio of 0.62. The business has a fifty day moving average of $9.44 and a two-hundred day moving average of $9.12. The stock has a market cap of $1.34 billion, a P/E ratio of 9.85, a PEG ratio of 2.10 and a beta of 0.84. Ardent Health, Inc. has a 52-week low of $7.71 and a 52-week high of $15.48.

Ardent Health (NYSE:ARDT) last issued its earnings results on Tuesday, May 5th. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.10. The company had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Ardent Health had a return on equity of 13.85% and a net margin of 2.09%.Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. On average, research analysts expect that Ardent Health, Inc. will post 1.12 earnings per share for the current year.

Analyst Upgrades and Downgrades

ARDT has been the subject of several analyst reports. Zacks Research upgraded Ardent Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 25th. Wall Street Zen upgraded Ardent Health from a “hold” rating to a “buy” rating in a report on Saturday, May 16th. Royal Bank Of Canada dropped their target price on Ardent Health from $14.00 to $13.00 and set an “outperform” rating for the company in a report on Monday, March 9th. UBS Group upped their target price on Ardent Health from $13.00 to $13.50 and gave the company a “buy” rating in a report on Thursday, May 7th. Finally, Leerink Partners dropped their target price on Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a report on Friday, March 6th. Seven research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $14.21.

Hedge Funds Weigh In On Ardent Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. The Manufacturers Life Insurance Company boosted its holdings in Ardent Health by 3.7% during the 1st quarter. The Manufacturers Life Insurance Company now owns 29,812 shares of the company’s stock valued at $255,000 after acquiring an additional 1,072 shares during the period. Geode Capital Management LLC boosted its holdings in Ardent Health by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock valued at $3,918,000 after acquiring an additional 1,769 shares during the period. Caitong International Asset Management Co. Ltd boosted its holdings in Ardent Health by 1,177.7% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock valued at $25,000 after acquiring an additional 2,638 shares during the period. Alliancebernstein L.P. boosted its holdings in Ardent Health by 24.8% during the 3rd quarter. Alliancebernstein L.P. now owns 16,472 shares of the company’s stock valued at $218,000 after acquiring an additional 3,272 shares during the period. Finally, New York State Common Retirement Fund boosted its holdings in Ardent Health by 121.4% during the 2nd quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after acquiring an additional 3,400 shares during the period.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.